Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | DHFR | P00374 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 6/20 | 0.59 |
| ▸ | CA2 | P00918 | 6/20 | 0.59 |
| ▸ | MMP1 | P03956 | 1/20 | 0.59 |
| ▸ | MMP2 | P08253 | 1/20 | 0.59 |
| ▸ | MMP9 | P14780 | 1/20 | 0.59 |
| ▸ | MMP8 | P22894 | 1/20 | 0.59 |
| ▸ | MMP13 | P45452 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | F2 | P00734 | 2/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.55 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.55 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfaguanidine SCHEMBL4347029 | 1.00 | TSHR (0.61) | TSHRTDP1DHFRSMN1; SMN2CA1 | |
| Sulfaguanidine SCHEMBL28848861 | 0.98 | TSHR (0.59) | TSHRTDP1DHFRSMN1; SMN2CA1 | |
| Sulfaguanidine SCHEMBL11754909 | 0.98 | TSHR (0.59) | TSHRTDP1DHFRSMN1; SMN2CA1 | |
| Sulfaguanidine SCHEMBL28627621 | 0.98 | TSHR (0.59) | TSHRTDP1DHFRSMN1; SMN2CA1 | |
| SCHEMBL10633357 | 0.82 | FLT1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL2933980 | 0.82 | MMP2 (0.57) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL8038636 | 0.82 | CA1 (0.57) | SMN1; SMN2CA1CA2MMP1MMP2 | |
| Sulfathiourea SCHEMBL27666346 | 0.82 | TSHR (0.59) | TSHRTDP1DHFRSMN1; SMN2CA1 | |
| SCHEMBL1269819 | 0.82 | CA2 (0.54) | CA1CA2MMP1MMP2MMP9 | |
| Sulfacarbamide SCHEMBL154846 | 0.82 | TSHR (0.69) | TSHRTDP1DHFRSMN1; SMN2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5440 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122054903-A | Perovskite light-emitting and photovoltaic dual-functional device and preparation method thereof | 郑州轻工业大学 | 2026-05-15 | — | — | CN | claimed |
| US-20260124609-A1 | PREPARATION METHOD OF DUAL-ANION CATALYST, AND USE OF DUAL-ANION CATALYST IN CATALYTIC DEGRADATION OF POLYURETHANE MATERIAL | ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) | 2026-05-07 | — | — | US | claimed |
| US-20260091119-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA | CELLIS AG (CH) | 2026-04-02 | — | — | US | claimed |
| CN-121570475-A | Application of sulfaguanidine in preparation of medicine for treating melanoma | 深圳市人民医院 | 2026-02-27 | — | — | CN | claimed |
| US-20260035351-A1 | SYNTHETIC METHOD OF SULFAMERAZINE | NANHAI BEISHA PHARMACEUTICAL CO LTD (CN) | 2026-02-05 | — | — | US | claimed |
| EP-4637829-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF OVARIAN CANCER | Cellis Sp. z o.o. ([Ltd.] (PL) | 2025-10-29 | — | — | EP | claimed |
| EP-4587062-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA | Cellis AG (CH) | 2025-07-23 | — | — | EP | claimed |
| US-12365875-B2 | Methods for generating skeletal muscle progenitor cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-22 | — | — | US | claimed |
| EP-3565887-B1 | METHODS FOR GENERATING SKELETAL MUSCLE PROGENITOR CELLS | UNIV CALIFORNIA (US) | 2025-07-16 | — | — | EP | claimed |
| CN-119432180-B | Antibacterial anti-adhesion ceramic coating and preparation method thereof | 江苏发银新材料有限公司 | 2025-05-23 | — | — | CN | claimed |
| US-4725355-A | SULFA DRUG ON SUPPORT | TERUMO KABUSHIKI KAISHA (JP) | 1988-02-16 | — | — | US | claimed |
| US-4661340-A | Quail egg based stabilized foam compositions for cosmetic purposes | INTERKEMIA VEGYIPARI GAZDASAGI TARSASAG (HU) | 1987-04-28 | — | — | US | claimed |
| US-4618580-A | AEROBIC CULTURING OF CORYNEBACTERIUM AND BREVIBACTERIUM MUTANTS | AJINOMOTO COMPANY, INCORPORATED (JP) | 1986-10-21 | — | — | US | claimed |
| US-4532245-A | Pharmaceutical compositions | HOFFMANN-LA ROCHE INC. (US) | 1985-07-30 | — | — | US | claimed |
| US-4315931-A | MICROBIOCIDES, INFECTIOUS DISEASES | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | claimed |
| US-4246358-A | POLYSULFONAMIDE FOAMS | MONSANTO RESEARCH CORPORATION (US) | 1981-01-20 | — | — | US | claimed |
| US-4169763-A | OF A CORYNEBACTERIA RESISTANT TO ASPARTIC ACID ANALOGS AND SULFA DRUGS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1979-10-02 | — | — | US | claimed |
| US-4094976-A | ANTICOCCIDIAL CYCLICAMINO ETHANOLS AND ESTERS THEREOF | MERCK & CO., INC. (US) | 1978-06-13 | — | — | US | claimed |
| US-3969188-A | Method of producing guanosine by fermentation | AJINOMOTO CO., INC. (JA) | 1976-07-13 | — | — | US | claimed |
| US-3960661-A | MUTANT BACILLUS SUBTILIS REQUIRING ADENINE FOR GROWTH | AJINOMOTO CO., INC. (JA) | 1976-06-01 | — | — | US | claimed |